New 6% hydroxyethyl starch 130/0.4 does not increase blood loss during major abdominal surgery-A randomized, controlled trial

Journal of the Formosan Medical Association

Volumn 113, Issue 7, 2014, Pages 429-435

  Hung, Ming Hui ^a,b   Zou, Conghua ^c   Lin, Feng Sheng ^a   Lin, Chen Jung ^a   Chan, Kuang Cheng ^a,b   Chen, Yanqing ^c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c FUJIAN PROVINCIAL HOSPITAL   (China)

Author keywords

Abdominal surgery; Blood coagulation; Fluid therapy; Hydroxyethyl starch; Tissue perfusion

Indexed keywords

ATRACURIUM BESILATE; CISATRACURIUM; FENTANYL; GLUCOSE; HETASTARCH; HYPERTENSIVE FACTOR; INOTROPIC AGENT; ISOFLURANE; MORPHINE; PLASMA SUBSTITUTE; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; THIOPENTAL; HETASTARCH DERIVATIVE; ISOTONIC SOLUTION; RINGER'S LACTATE;

ABDOMINAL SURGERY; ADULT; ANESTHESIA INDUCTION; ARTERIAL PRESSURE; ARTICLE; BLEEDING; BLOOD CLOT; BLOOD CLOTTING; CENTRAL VENOUS OXYGEN SATURATION; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; CRYSTALLOID; FEMALE; FLUID THERAPY; HEART INDEX; HEART RATE; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; HYPOCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; NEUROMUSCULAR BLOCKING; PEROPERATIVE CARE; POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; THROMBOELASTOGRAPHY; TISSUE PERFUSION; VENOUS OXYGEN TENSION; ABDOMEN; COMPARATIVE STUDY; DRUG EFFECTS; MIDDLE AGED; OPERATIVE BLOOD LOSS; PROCEDURES; SURGERY;

ABDOMEN; ADULT; BLOOD COAGULATION; BLOOD LOSS, SURGICAL; FEMALE; FLUID THERAPY; HEMODYNAMICS; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; ISOTONIC SOLUTIONS; MALE; MIDDLE AGED; PLASMA SUBSTITUTES; THROMBELASTOGRAPHY;

EID: 84902798915     PISSN: 09296646     EISSN: 18760821     Source Type: Journal    
DOI: 10.1016/j.jfma.2012.08.002     Document Type: Article

References (26)

1. Boldt J. New light on intravascular volume replacement regimens: what did we learn from the past three years?. Anesth Analg 2003, 97:1595-1604.
2. Grocott M.P., Mythen M.G., Gan T.J. Perioperative fluid management and clinical outcomes in adults. Anesth Analg 2005, 100:1093-1106.
3. Kehlet H., Bundgaard-Nielsen M. Goal-directed perioperative fluid management: why, when, and how?. Anesthesiology 2009, 110:453-455.
4. Johnston W.E. PRO: fluid restriction in cardiac patients for noncardiac surgery is beneficial. Anesth Analg 2006, 102:340-343.
5. Spahn D.R., Chassot P.G. CON: fluid restriction for cardiac patients during major noncardiac surgery should be replaced by goal-directed intravascular fluid administration. Anesth Analg 2006, 102:344-346.
6. Holte K., Sharrock N.E., Kehlet H. Pathophysiology and clinical implications of perioperative fluid excess. Br J Anaesth 2002, 89:622-632.
7. Kozek-Langenecker S.A. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005, 103:654-660.
8. Chappell D., Jacob M., Hofmann-Kiefer K., Conzen P., Rehm M. A rational approach to perioperative fluid management. Anesthesiology 2008, 109:723-740.
9. Treib J., Baron J.F., Grauer M.T., Strauss R.G. An international view of hydroxyethyl starches. Intensive Care Med 1999, 25:258-268.
10. Hiltebrand L.B., Kimberger O., Arnberger M., Brandt S., Kurz A., Sigurdsson G.H. Crystalloids versus colloids for goal-directed fluid therapy in major surgery. Crit Care 2009, 13:R40.
11. Bundgaard-Nielsen M., Holte K., Secher N.H., Kehlet H. Monitoring of peri-operative fluid administration by individualized goal-directed therapy. Acta Anaesthesiol Scand 2007, 51:331-340.
12. Manecke G.R. Edwards FloTrac sensor and Vigileo monitor: easy, accurate, reliable cardiac output assessment using the arterial pulse wave. Expert Rev Med Devices 2005, 2:523-527.
13. Walley K.R. Use of central venous oxygen saturation to guide therapy. Am J Respir Crit Care Med 2011, 184:514-520.
14. Hobson A.R., Agarwala R.A., Swallow R.A., Dawkins K.D., Curzen N.P. Thrombelastography: current clinical applications and its potential role in interventional cardiology. Platelets 2006, 17:509-518.
15. Anaya D.A., Nathens A.B. Thrombosis and coagulation: deep vein thrombosis and pulmonary embolism prophylaxis. Surg Clin North Am 2005, 85:1163-1177.
16. Ruttmann T.G. The effect of haemodilution on coagulation. Br JAnaesth 2003, 90:809.
17. Ruttmann T.G., James M.F., Finlayson J. Effects on coagulation of intravenous crystalloid or colloid in patients undergoing peripheral vascular surgery. Br J Anaesth 2002, 89:226-230.
18. Ruttmann T.G., Jamest M.F., Lombard E.H. Haemodilution-induced enhancement of coagulation is attenuated invitro by restoring antithrombin III to pre-dilution concentrations. Anaesth Intensive Care 2001, 29:489-493.
19. Ruttmann T.G., James M.F., Aronson I. Invivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation. Br J Anaesth 1998, 80:612-616.
20. de Jonge E., Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 2001, 29:1261-1267.
21. Sanfelippo M.J., Suberviola P.D., Geimer N.F. Development of a von Willebrand-like syndrome after prolonged use of hydroxyethyl starch. Am J Clin Pathol 1987, 88:653-655.
22. Strauss R.G., Pennell B.J., Stump D.C. A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch. Transfusion 2002, 42:27-36.
23. Jamnicki M., Zollinger A., Seifert B., Popovic D., Pasch T., Spahn D.R. Compromised blood coagulation: an invitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography. Anesth Analg 1998, 87:989-993.
24. Lang K., Boldt J., Suttner S., Haisch G. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg 2001, 93:405-409.
25. Mythen M.G., Webb A.R. Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg 1995, 130:423-429.
26. Boldt J. Modern rapidly degradable hydroxyethyl starches: current concepts. Anesth Analg 2009, 108:1574-1582.